Valio Ltd.
Records under this name other than the patents Valio Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 23 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,829,130 | Process for producing a lactose-free milk product Formerly held Term ended Term ended Jan 18, 2026 · From the USPTO record | Term ended | Term ended Jan 18, 2026 | From the USPTO record |
| US 8,445,426 | Peptides and methods for producing them Formerly held Lapsed on the fee record Ended May 21, 2025 · From the USPTO record | Lapsed on the fee record | Ended May 21, 2025 | From the USPTO record |
| US 8,309,073 | Combination of probiotics Formerly held Term ended Term ended Sep 20, 2024 · From the USPTO record | Term ended | Term ended Sep 20, 2024 | From the USPTO record |
| US 8,449,938 | Lactose-free milk product and processes for producing the same Term ended Term ended Feb 10, 2024 · From the USPTO record | Term ended | Term ended Feb 10, 2024 | From the USPTO record |
| US 10,085,462 | Process for preserving low-lactose or lactose-free milk product Lapsed on the fee record Ended Oct 2, 2022 · From the USPTO record | Lapsed on the fee record | Ended Oct 2, 2022 | From the USPTO record |
| US 10,080,372 | Low-lactose and lactose-free milk product and process for production thereof Lapsed on the fee record Ended Sep 25, 2022 · From the USPTO record | Lapsed on the fee record | Ended Sep 25, 2022 | From the USPTO record |
| US 8,604,005 | Use of probiotics Formerly held Lapsed on the fee record Ended Dec 10, 2021 · From the USPTO record | Lapsed on the fee record | Ended Dec 10, 2021 | From the USPTO record |
| US 6,399,140 | Whey salt powder, process for its production and its use Term ended Term ended Sep 29, 2020 · From the USPTO record | Term ended | Term ended Sep 29, 2020 | From the USPTO record |
| US 6,972,282 | Process for producing a product containing antihypertensive tripeptides Lapsed on the fee record Ended Dec 6, 2013 · From the USPTO record | Lapsed on the fee record | Ended Dec 6, 2013 | From the USPTO record |
| US 6,890,529 | Lactobacillus helveticus producing antihypertensive di- and tripeptides Lapsed on the fee record Ended May 10, 2013 · From the USPTO record | Lapsed on the fee record | Ended May 10, 2013 | From the USPTO record |